Market Overview

Cryo-Save Group NV: board change


Cryo-Save Group N.V. (Euronext: CRYO, 'Cryo-Save', or 'the Group'), the leading international family stem cell bank and the largest bank in Europe, announces that Marc Waeterschoot has stepped down as Non-Executive Director for personal reasons. Mr. Waeterschoot, co-founder of the Company, has been actively involved in Cryo-Save for over 12 years and will remain a shareholder in the Company. 

Johan Goossens, Chairman Cryo-Save

"Marc's vision and leadership have shaped Cryo-Save into the successful company it is today. We are very grateful for his contributions and support. His knowledge of the stem cell industry and insights have been of great value all these years.

Enquiries:

Cryo-Save Group + 31 575 548 998
Ann Van Gysel, CCO ad interim

About Cryo-Save (www.cryo-save.com/group)

Cryo-Save, the leading international family stem cell bank and largest bank in Europe, stores more than 225,000 samples from cord blood and umbilical cord tissue for newborns and adipose tissue for adults. These stem cells can mean the difference between life and death in the case of future threats to the health of the donors. There are already many diseases treatable by the use of stem cells, and the number of treatments will only increase. Driven by its international business strategy, Cryo-Save is now represented in over 40 countries on three continents, with ultra-modern processing and storage facilities in Belgium, Germany, Dubai, India and South Africa.






This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients.

The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the
information contained therein.

Source: Cryo-Save Group N.V. via Thomson Reuters ONE

HUG#1660462

 

Around the Web, We're Loving...

Get Benzinga's Newsletters